European Archives - Page 393 of 1016 - European Medical Journal

Antimicrobial Resistance - a persistent global health threat and how microbiology can help combat it

In this episode we discuss the root causes of the AMR emergence, the cost of it to the patients and the wider population.

Infographic: Bladder Cancer

Bladder cancer is a prevalent disease with defined risk factors and many paths for treatment options. This infographic provides an overview of detection modes and tumour stages, and highlights examinations used to detect bladder cancer.

Microbiology Testing and Its Role in Combating Antimicrobial Resistance and in Assuring the Best Patient Outcomes

This podcast explores the vital role that microbiology testing will play in countering the impending challenge that antimicrobial resistance presents.

Embolic Protection Found to Reduce Severity of Post-TAVR Stroke

Cerebral embolism protection can improve survival and reduce the severity of procedure-related strokes in patients who have had transcatheter aortic valve replacement…

Complete Revascularisation Improves Quality of Life After STEMI

A novel sub-study has revealed that complete revascularisation improves angina-related quality of life in patients with ST-segment elevation myocardial infarction…

Integrated Framework for Aerodigestive Conditions Benefits Patients

VALUABLE advances in the diagnosis of aerodigestive conditions have been made with the introduction of a new integrated framework…

Lifetime Management for Patients with Oesophageal Malformations

Oesophageal atresia (OA) is a birth defect that causes the oesophagus to end in a pouch rather than connecting to the stomach…

Meet GOLD's next catalyst - digital innovator, Davidek Herron

Marc presents exclusive snippets from an interview with our next catalist, Davidek Herron, Global Head of Digital, Roche.

Clinical Implications of Emerging Metastatic Breast Cancer Data from ESMO 2021: Interviews with Two Key Opinion Leaders

Around 15–20% of breast cancers are characterised by amplification or overexpression of human epidermal growth factor receptor 2 (HER2)…

EMJ Oncology 10 [Supplement 7] 2022

EMJ had the pleasure of interviewing leading specialists in the field of breast cancer: Javier Cortés, International Breast Cancer Center, Quiron Group, Barcelona, Spain, and Giuseppe Curigliano, European Institute of Oncology (IEO), Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rionero in Vulture, and University of Milano, Milan, Italy